Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126084561 | 12608456 | 1 | I | 20110621 | 20160726 | 20160729 | 20160729 | EXP | PHHY2016PK103547 | NOVARTIS | 68.19 | YR | M | Y | 0.00000 | 20160729 | CN | COUNTRY NOT SPECIFIED | PK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126084561 | 12608456 | 1 | PS | DIOVAN | VALSARTAN | 1 | Oral | 80 MG, BID | 21283 | 80 | MG | FILM-COATED TABLET | BID | ||||||
| 126084561 | 12608456 | 2 | SS | DIOVAN | VALSARTAN | 1 | Oral | 160 MG, BID | 21283 | 160 | MG | FILM-COATED TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126084561 | 12608456 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126084561 | 12608456 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126084561 | 12608456 | Blood pressure increased | |
| 126084561 | 12608456 | Prostatic disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126084561 | 12608456 | 1 | 20000725 | 20110720 | 0 | |
| 126084561 | 12608456 | 2 | 20110721 | 0 |